Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial
Abstract Introduction Products based on inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) combinations may provide different clinical benefits. This study was conducted to compare the rapid effects of three such combination products: formoterol/fluticasone (FFC) aerosol (pMDI), formoterol/b...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2018-09-01
|
Series: | Pulmonary Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s41030-018-0062-x |